MedPath

Intranasal Azelastine and Fluticasone combination in the treatment of adolescents with Allergic Rhinitis

Not Applicable
Recruiting
Conditions
Allergic rhinitis, unspecified
Adolescent
J30.4
M01.060.057
Registration Number
RBR-6pswj7
Lead Sponsor
Hospital São Paulo - Universidade Federal de São Paulo
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Not specified
Target Recruitment
Not specified
Inclusion Criteria

Adolescents between 12 and 18 years old; both genders; difficult to control moderate-severe persistent allergic rhinitis diagnosis; positive cutaneous immediate hypersensitivity test or specific serum IgE to inhalant allergens

Exclusion Criteria

Uncontrolled asthma; significant anatomical defects of the upper airway; systemic disease cognitive deficits; upper airways infection in the last 3 weeks; in use of systemic corticosteroid (last 30 days); in use of specific immunotherapy and immunosuppressants.

Study & Design

Study Type
Intervention
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath